Revvity, Inc. NYSE:RVTY

Revvity stock price today

$91.42
-20.56
-18.37%
Financial Health
0
1
2
3
4
5
6
7
8
9

Revvity stock price monthly change

+2.25%
month

Revvity stock price quarterly change

+2.25%
quarter

Revvity stock price yearly change

+1.17%
year

Revvity key metrics

Market Cap
13.47B
Enterprise value
15.71B
P/E
49.63
EV/Sales
5.77
EV/EBITDA
19.07
Price/Sales
5.00
Price/Book
1.73
PEG ratio
64.03
EPS
1.39
Revenue
2.72B
EBITDA
741.09M
Income
149.63M
Revenue Q/Q
-3.69%
Revenue Y/Y
-9.85%
Profit margin
10.18%
Oper. margin
11.79%
Gross margin
48.8%
EBIT margin
11.79%
EBITDA margin
27.19%
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Revvity stock price history

Revvity stock forecast

Revvity financial statements

Average Price Target
Last Year

$136

Potential upside: 48.76%

Based on estimate of 2 analysts
  • Analysts Price target

  • Financials & Ratios estimates

Revvity, Inc. (NYSE:RVTY): Profit margin
Jun 2023 709.06M 35.55M 5.01%
Sep 2023 670.73M 9.49M 1.42%
Dec 2023 695.90M 78.56M 11.29%
Mar 2024 649.92M 26.01M 4%
0.25%
Yield TTM
Revvity, Inc. (NYSE:RVTY): Payout ratio
Payout ratio 12.47%
Revvity, Inc. (NYSE:RVTY): Dividend Yield
2019 0.29%
2020 0.19%
2021 0.14%
2022 0.2%
2023 0.25%
Revvity, Inc. (NYSE:RVTY): Debt to assets
Jun 2023 14218549000 6.34B 44.65%
Sep 2023 13421548000 5.72B 42.67%
Dec 2023 13564665000 5.69B 41.96%
Mar 2024 13432705000 5.58B 41.59%
Revvity, Inc. (NYSE:RVTY): Cash Flow
Jun 2023 -135.31M -571.04M -228.27M
Sep 2023 -33.48M 434.86M -586.04M
Dec 2023 196.61M -414.80M -19.61M
Mar 2024 147.56M -18.18M -35.01M

Revvity alternative data

Revvity, Inc. (NYSE:RVTY): Employee count
Sep 2023 11,000
Oct 2023 11,000
Nov 2023 11,000
Dec 2023 11,000
Jan 2024 11,000
Feb 2024 11,000
Mar 2024 11,500
Apr 2024 11,500
May 2024 11,500
Jun 2024 11,000
Jul 2024 11,000

Revvity other data

Revvity, Inc. (NYSE:RVTY): Insider trades (number of shares)
Period Buy Sel
Feb 2024 0 51589
Jun 2024 0 4000
Aug 2024 0 4350
Oct 2024 0 6461
Dec 2024 0 18365
Transaction Date Insider Security Shares Price per share Total value Source
Option
SINGH PRAHLAD R. director, officer.. Common Stock 18,365 $81.29 $1,492,891
Sale
SINGH PRAHLAD R. director, officer.. Common Stock 15,088 $116.13 $1,752,169
Sale
SINGH PRAHLAD R. director, officer.. Common Stock 3,277 $116.63 $382,197
Option
SINGH PRAHLAD R. director, officer.. NQ Stock Option (right to buy) 18,365 $81.29 $1,492,891
Sale
VOHRA TAJINDER S officer: Please S.. Common Stock 2,134 $121.72 $259,750
Sale
VOHRA TAJINDER S officer: Please S.. Common Stock 20 $122.56 $2,451
Sale
VOHRA TAJINDER S officer: Please S.. Common Stock 1,661 $122.47 $203,423
Sale
VOHRA TAJINDER S officer: Please S.. Common Stock 493 $122.99 $60,634
Sale
VOHRA TAJINDER S officer: Please S.. Common Stock 2,053 $122.04 $250,548
Sale
VOHRA TAJINDER S officer: Please S.. Common Stock 100 $123.05 $12,305
Tuesday, 17 December 2024
businesswire.com
Monday, 16 December 2024
seekingalpha.com
Wednesday, 4 December 2024
zacks.com
Wednesday, 20 November 2024
businesswire.com
Tuesday, 5 November 2024
benzinga.com
Monday, 4 November 2024
zacks.com
seekingalpha.com
zacks.com
zacks.com
reuters.com
businesswire.com
Friday, 1 November 2024
zacks.com
Monday, 28 October 2024
zacks.com
Thursday, 24 October 2024
businesswire.com
Wednesday, 23 October 2024
zacks.com
Tuesday, 22 October 2024
businesswire.com
Thursday, 10 October 2024
zacks.com
Monday, 7 October 2024
zacks.com
Friday, 6 September 2024
zacks.com
Monday, 26 August 2024
zacks.com
Friday, 9 August 2024
zacks.com
Monday, 29 July 2024
zacks.com
investopedia.com
seekingalpha.com
zacks.com
reuters.com
zacks.com
businesswire.com
Monday, 22 July 2024
zacks.com
Friday, 19 July 2024
zacks.com
  • What's the price of Revvity stock today?

    One share of Revvity stock can currently be purchased for approximately $91.42.

  • When is Revvity's next earnings date?

    Unfortunately, Revvity's (RVTY) next earnings date is currently unknown.

  • Does Revvity pay dividends?

    Yes, Revvity pays dividends and its trailing 12-month yield is 0.25% with 12% payout ratio. The last Revvity stock dividend of undefined was paid on 6 Sep 2025.

  • How much money does Revvity make?

    Revvity has a market capitalization of 13.47B and it's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 16.95% to 2.75B US dollars.

  • What is Revvity's stock symbol?

    Revvity, Inc. is traded on the NYSE under the ticker symbol "RVTY".

  • What is Revvity's primary industry?

    Company operates in the Healthcare sector and Medical - Diagnostics & Research industry.

  • How do i buy shares of Revvity?

    Shares of Revvity can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • How many employees does Revvity have?

    As Jul 2024, Revvity employs 11,000 workers, which is 4% less then previous quarter.

  • When Revvity went public?

    Revvity, Inc. is publicly traded company for more then 60 years since IPO on 6 Jul 1965.

  • What is Revvity's official website?

    The official website for Revvity is perkinelmer.com.

  • Where are Revvity's headquarters?

    Revvity is headquartered at 940 Winter Street, Waltham, MA.

  • How can i contact Revvity?

    Revvity's mailing address is 940 Winter Street, Waltham, MA and company can be reached via phone at +7 816636900.

  • What is Revvity stock forecast & price target?

    Based on 2 Wall Street analysts` predicted price targets for Revvity in the last 12 months, the avarage price target is $136. The average price target represents a 48.76% change from the last price of $91.42.

Revvity company profile:

Revvity, Inc.

perkinelmer.com
Exchange:

NYSE

Full time employees:

11,000

Industry:

Medical - Diagnostics & Research

Sector:

Healthcare

Revvity, Inc. provides products, services, and solutions to the diagnostics, life sciences, and applied services markets worldwide. It operates through two segments, Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection, and imaging technologies that enable scientists to enhance research breakthroughs in the life sciences research market, as well as contract research and laboratory services. It also provides analytical technologies, solutions, and services for its customers to understand the characterize the health of various aspects, including air, water, and soil. In addition, this segment offers solutions to farmers and food producers; and analytical instrumentation for the industrial market, which includes the chemical, semiconductor and electronics, energy, lubricant, petrochemical, and polymer industries. The Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market. Its products are used for testing and screening genetic abnormalities, disorders, and diseases, including down syndrome, hypothyroidism, muscular dystrophy, infertility, and various metabolic conditions. This segment also develops technologies that enable and support genomic workflows using protein coupled receptor and next-generation DNA sequencing for applications in oncology, immunodiagnostics, and drug discovery. It serves pharmaceutical and biotechnology companies, laboratories, academic and research institutions, public health authorities, private healthcare organizations, doctors, and government agencies. The company was formerly known as PerkinElmer, Inc. and changed its name to Revvity, Inc. in April 2023. Revvity, Inc. was founded in 1937 and is headquartered in Waltham, Massachusetts.

940 Winter Street
Waltham, MA 02451

CIK: 0000031791
ISIN: US7140461093
CUSIP: 714046109